Suchergebnisse - (Person:"Federico, Stephanie")

PubPharm (82)

31

Targeting Protein Kinase CK1δ with Riluzole : Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?

enthalten in: ChemMedChem | 2018

von Bissaro, M. | Federico, S. | Salmaso, V. | +3

32

1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists : Modifications at the 8 position to reach selectivity towards A3 adenosine receptor subtype

enthalten in: European journal of medicinal chemistry | 2018

von Federico, S. | Margiotta, E. | Salmaso, V. | +5

33

A2A Adenosine Receptor Antagonists as Therapeutic Candidates : Are They Still an Interesting Challenge?

enthalten in: Mini reviews in medicinal chemistry | 2018

von Cacciari, B. | Spalluto, G. | Federico, S.

34

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment

enthalten in: PloS one | 2018

von Shao, Y. | Ma, X. | Paira, P. | +11

35

A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?

enthalten in: Mini-reviews in ... medicinal chemistry | 2018

von Cacciari, B. | Spalluto, G. | Federico, S.

36

Impact of protein–ligand solvation and desolvation on transition state thermodynamic properties of adenosine $ A_{2A} $ ligand binding kinetics

enthalten in: In Silico Pharmacology | 2017

von Deganutti, G. | Zhukov, A. | Deflorian, F. | +6

37

Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics

enthalten in: In silico pharmacology | 2017

von Deganutti, G. | Zhukov, A. | Deflorian, F. | +6

38

5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors

enthalten in: European journal of medicinal chemistry | 2016

von Federico, S. | Ciancetta, A. | Porta, N. | +6

39

Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists

enthalten in: Current topics in medicinal chemistry | 2016

von Redenti, S. | Ciancetta, A. | Pastorin, G. | +4

40

5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors

enthalten in: European journal of medicinal chemistry | 2016

von Ciancetta, A. | Cacciari, B. | Pastorin, G. | +6